The core technology of the Molecular Medical & Healthcare Platform presented by the CDBIO Foundation is molecular sensor technology using lithium Endohedral Fullerene. Li⁺@C60 (Lithium Endohedral Fullerene), successfully commercialized for the first time in the world through joint research by Dr. Eunsang Kwon, a world-renowned scholar at the Research and Analytical Center for Giant Molecules in Japan (Tohoku Univ), and Dr. Yasuhiko Kasama, CEO of Idea International, is the most important type of Endohedral Metallofullerene as a newly emerging carbon nano material.

Lithium Endohedral Fullerene has the lowest energy level among substances developed or discovered so far.

Energy levels are the energy values of quantized states where electrons formed in quantum mechanics, such as atoms, molecules, or solid materials, can exist.

Lithium Endohedral Fullerene is a state-of-the-art diagnostic sensor that can accurately diagnose disease-causing substances in molecular units, and it can measure the energy level of disease-causing substances to check the occurrence and progress of disease.